Chemistry Reference
In-Depth Information
35. Hennenfent KL, Govindan R. Novel formulations of taxanes: a review. Old wine in
a new bottle? Ann. Oncol. 2006;17:735-749.
36. Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA. Plant antitumor
agents. 1. The isolation and structure of camptothecin, a novel alkaloidal leukemia
and tumor inhibitor from Camptotheca acuminate. J. Am. Chem. Soc. 1966;88:
3888-3890.
37. Wall ME. In: Chronicles of Drug Discovery, Volume 3. Lednicer D, ed. 1993.
American Chemical Society, Washington D.C., pp. 327-348.
38. Covey JM, Jaxel C, Kohn KW, Pommier Y. Protein-linked DNA strand breaks
induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer
Res. 1989;49:5016-5022.
39. Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM. Irinotecan
in the treatment of colorectal cancer: clinical overview. J. Clin. Oncol. 2001;19:
1501-1518.
40. Wang HK, Liu SY, Hwang KM, Taylor G, Lee KH. Synthesis of novel water-soluble
7-(aminoacylhydrazone)-formyl camptothecins with potent inhibition of DNA topoi-
somerase I. Bioorg. Med. Chem. 1994;2:1397-1402.
41. Dallavalle S, Merlini L, Morini G, Muso L, Penco S, Beretta GL, Tinelli S, Zunino
F. Synthesis and cytotoxic activity of substituted 7-aryliminomethyl derivatives of
camptothecin. Eur. J. Med. Chem. 2004;39:507-513.
42. Bastow KF, Wang HK, Cheng YC, Lee KH. Antitumor agents 173. Synthesis and
evaluation of camptothecin-4
β
-amino-4
-O-demethyl epipodophyllotoxin conjugates
as inhibitors of mammalian DNA topoisomerases and as cytotoxic agents. Bioorg.
Med. Chem. 1997;5:1481-1488.
43. O'Leary J, Muggia FM. Camptothecins: a review of their development and schedules
of administration. Eur. J. Cancer 1998;34:1500-1508.
44. Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience,
pharmacology, and continued development of the camptothecins. Clin. Cancer Res.
2002;8:641-661.
45. Thomas CJ, Rahier NJ, Hecht SM. Camptothecin: current perspectives. Bioorg. Med.
Chem. 2004;12:1585-1604.
46. Du W, Kaskar B, Blumbergs P, Subramanian PK, Curran DP. Semisynthesis of
DB-67 and other silatecans from camptothecin by thiol-promoted addition of silyl
radicals. Bioorg. Med. Chem. 2003;11:451-458.
47. Clark JW. Rubitecan. Expert Opin. Investig. Drugs 2006;15:71-79.
48. Imbert TF. Discovery of podophyllotoxins. Biochimie 1998;80:207-222.
49. Lee KH, Imakura Y, Haruna M, Beers SA, Thurston LS, Dai HJ, Chen CH, Liu SY,
Chan YC. New cytotoxic 4-alkylamino analogues of 4
-demethyl-epipodophyllotoxin
as inhibitors of human DNA topoisomerase II. J. Nat. Prod. 1989;52:606-613.
50. Chang JY, Han FS, Liu SY, Wang HK, Lee KH, Cheng YC. Effect of 4-
β
-
arylamino derivatives of 4
-O-demethylpodophyllotoxin on human DNA topoiso-
merase II, tubulin polymerization. KB cells, and their resistant variants. Cancer Res.
1991;51:1755-1759.
51. Wang ZW, Kuo YH, Schnur D, Bowen JP, Liu SY, Han FS, Chan JY, Chen YC,
Lee KH. New 4
β
-arylamino derivatives of 4
-O-demethylepipodophyllotoxin and
related compounds as potent inhibitors of human DNA topoisomerase II. J. Med.
Chem. 1990;33:2660-2666.
